Evidence map›Paper›PMID 29445431›Full record

ArticleJournal of vascular and interventional neurology2017

Outcome, Recurrence and Mortality after Non-Valvular Atrial Fibrillation Stroke: Long-Term Follow-Up Study.

Antonio Arauz, Francisco Ruiz-Navarro, Miguel A Barboza, Angelica Ruiz, Jonathan Colin, Marisela Reyes, Humberto Silos, Carlos Cantu-Brito, Luis Murillo-Bonilla, Fernando Barinagarrementeria

Open access · greenAbstract read
In one paragraph

Article in Journal of vascular and interventional neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Antonio ArauzStroke Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Francisco Ruiz-NavarroStroke Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Miguel A BarbozaStroke Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Angelica RuizStroke Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Jonathan ColinStroke Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Marisela ReyesStroke Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Humberto SilosStroke Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Carlos Cantu-BritoStroke Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Luis Murillo-BonillaStroke Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Fernando BarinagarrementeriaStroke Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Instituto Nacional de Neurología y Neurocirugía · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveNon-valvular atrial fibrillation (NVAF) is a major risk factor for ischemic stroke (IS) and a powerful predictor of mortality. This study investigates early and long-term outcome among patients with IS secondary to NVAF and identify the main factors associated with poor outcome, recurrence, and death.

methodsWe analyzed the data from our consecutive NVAF acute IS database, over a period of 23 years. The endpoints were bad outcome (Modified Rankin Score ≥3), recurrence, and mortality at discharge, after 6 months, 12 months, and final follow-up. Multivariate Cox and Kaplan-Meier analysis were used to estimate the probability of death.

results129 consecutive acute IS patients were included (77 [59.7%] females, mean age 70.2 ± 10.1 years). Discharge, 6 and 12 months bad outcome was 62%, 63%, and 61%, respectively. After a median follow-up of 17 months (IQR 6-54.5), 35.6% patients had bad outcome, 21.7% had recurrence and 36.4% died. The recurrence and death annual rates were 19.1% and 6.32%. The absence of oral anticoagulation (OAC) and NIHSS score > 12 were the strongest predictors of mortality.

conclusionsIS secondary to NVAF has a high rate of stroke recurrence and mortality in our population, with the absence of OAC and major stroke as the main risk factors.

Indexed as

cardioembolic strokeischemic strokenon-valvular atrial fibrillationoral anticoagulationprognosisstroke outcome

Identifiers

PMID29445431
PMCPMC5805901
OpenAlexW2991829949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.